{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:20:13Z","timestamp":1790738413646,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1124\/molpharm.121.000359","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T14:45:21Z","timestamp":1632494721000},"page":"568-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["\u03b2-Arrestin\u2013Biased Allosteric Modulator Potentiates Carvedilol-Stimulated \u03b2 Adrenergic Receptor Cardioprotection"],"prefix":"10.1016","volume":"100","author":[{"given":"Jialu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswaranjan","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Gokhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alem W.","family":"Kahsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungkirl","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lefkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Rockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.121.000359_bib1","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1074\/jbc.M808463200","article-title":"beta-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation","volume":"284","author":"Ahn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000359_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.118.111948","article-title":"Small-molecule positive allosteric modulators of the \u03b22-adrenoceptor isolated from DNA-encoded libraries","volume":"94","author":"Ahn","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000359_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2017.11.003","article-title":"A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes","volume":"114","author":"Bayoumi","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/molpharm.121.000359_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.2552582","article-title":"Beta-adrenergic receptor kinase: primary structure delineates a multigene family","volume":"246","author":"Benovic","year":"1989","journal-title":"Science"},{"key":"10.1124\/molpharm.121.000359_bib5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2017.03.563","article-title":"Achieving a maximally tolerated \u03b2-blocker dose in heart failure patients: is there room for improvement?","volume":"69","author":"Bhatt","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/molpharm.121.000359_bib6","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1124\/molpharm.121.000359_bib7","first-page":"2","article-title":"Beta-blockers for heart failure","author":"Cleland","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/molpharm.121.000359_bib8","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1161\/01.CIR.100.22.2210","article-title":"Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein","volume":"100","author":"Communal","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/molpharm.121.000359_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0026-895X(24)12621-1","article-title":"Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice","volume":"60","author":"Devic","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000359_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.11.031","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)","volume":"111","author":"DiNicolantonio","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1124\/molpharm.121.000359_bib11","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1073\/pnas.96.12.7059","article-title":"Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice","volume":"96","author":"Engelhardt","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000359_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yjmcc.2014.02.009","article-title":"\u03b2-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1\/2 and Akt","volume":"72","author":"Grisanti","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/molpharm.121.000359_bib13","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.7150\/thno.26619","article-title":"Pepducin-mediated cardioprotection via \u03b2-arrestin-biased \u03b22-adrenergic receptor-specific signaling","volume":"8","author":"Grisanti","year":"2018","journal-title":"Theranostics"},{"key":"10.1124\/molpharm.121.000359_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0033-0620(74)90039-5","article-title":"Cardiovascular injury induced by sympathetic catecholamines","volume":"17","author":"Haft","year":"1974","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1124\/molpharm.121.000359_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/molpharm.121.000359_bib16","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.1073\/pnas.0804745105","article-title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000359_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCRESAHA.114.302766","article-title":"\u03b2-arrestin1-biased \u03b21-adrenergic receptor signaling regulates microRNA processing","volume":"114","author":"Kim","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.121.000359_bib18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.92.6.1499","article-title":"Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure","volume":"92","author":"Krum","year":"1995","journal-title":"Circulation"},{"key":"10.1124\/molpharm.121.000359_bib19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nchembio.2431","article-title":"A kinetic view of GPCR allostery and biased agonism","volume":"13","author":"Lane","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1124\/molpharm.121.000359_bib20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.aaw8981","article-title":"Mechanism of \u03b22AR regulation by an intracellular positive allosteric modulator","volume":"364","author":"Liu","year":"2019","journal-title":"Science"},{"key":"10.1124\/molpharm.121.000359_bib21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.2163110","article-title":"beta-Arrestin: a protein that regulates beta-adrenergic receptor function","volume":"248","author":"Lohse","year":"1990","journal-title":"Science"},{"key":"10.1124\/molpharm.121.000359_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat7650","article-title":"Manifold roles of \u03b2-arrestins in GPCR signaling elucidated with siRNA and CRISPR\/Cas9","volume":"11","author":"Luttrell","year":"2018","journal-title":"Sci Signal"},{"key":"10.1124\/molpharm.121.000359_bib23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1124\/molpharm.121.000359_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/CIRCRESAHA.117.310520","article-title":"Adrenergic receptors in individual ventricular myocytes: the beta-1 and alpha-1B are in all cells, the alpha-1A is in a subpopulation, and the beta-2 and beta-3 are mostly absent","volume":"120","author":"Myagmar","year":"2017","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.121.000359_bib25","doi-asserted-by":"crossref","first-page":"12178","DOI":"10.1038\/ncomms12178","article-title":"Monitoring G protein-coupled receptor and \u03b2-arrestin trafficking in live cells using enhanced bystander BRET","volume":"7","author":"Namkung","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.121.000359_bib26","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1172\/JCI31901","article-title":"Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection","volume":"117","author":"Noma","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.121.000359_bib27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.121.000359_bib28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.121.000359_bib10658559","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/molpharm.121.000363","article-title":"Unique positive cooperativity between the \u03b2-arrestin-biased \u03b2-blocker carvedilol and a small molecule positive allosteric modulator of the \u03b22-adrenergic receptor","volume":"100","author":"Pani","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000359_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/molpharm.121.000359_bib30","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2000769","article-title":"beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress","volume":"3","author":"Rakesh","year":"2010","journal-title":"Sci Signal"},{"key":"10.1124\/molpharm.121.000359_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-transmembrane-spanning receptors and heart function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000359_bib32","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1073\/pnas.1722336115","article-title":"Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in \u03b2-arrestin coupling","volume":"115","author":"Staus","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000359_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-018-0259-z","article-title":"Structural insights into G-protein-coupled receptor allostery","volume":"559","author":"Thal","year":"2018","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000359_bib34","doi-asserted-by":"crossref","first-page":"20375","DOI":"10.1074\/jbc.M109.005793","article-title":"beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling","volume":"284","author":"Tilley","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000359_bib35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-protein-coupled receptors in heart disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.121.000359_bib36","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41467-017-01855-z","article-title":"G\u03b1i is required for carvedilol-induced \u03b21 adrenergic receptor \u03b2-arrestin biased signaling","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.121.000359_bib37","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1073\/pnas.0611448104","article-title":"A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein","volume":"104","author":"Whorton","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000359_bib38","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000359_bib39","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.117.028194","article-title":"Biased G protein-coupled receptor signaling: changing the paradigm of drug discovery","volume":"137","author":"Wisler","year":"2018","journal-title":"Circulation"},{"key":"10.1124\/molpharm.121.000359_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/aps.2011.201","article-title":"\u03b2-Adrenergic receptor subtype signaling in heart: from bench to bedside","volume":"33","author":"Woo","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/molpharm.121.000359_bib41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"key":"10.1124\/molpharm.121.000359_bib42","doi-asserted-by":"crossref","first-page":"H1377","DOI":"10.1152\/ajpheart.00504.2009","article-title":"Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction","volume":"297","author":"Yoo","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.121.000359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:48:31Z","timestamp":1739954911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24011994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0026895X24011994"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.121.000359","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Arrestin\u2013Biased Allosteric Modulator Potentiates Carvedilol-Stimulated \u03b2 Adrenergic Receptor Cardioprotection","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.121.000359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}